Controlled release chromium picolinate
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 5, 2000
Grant Date -
N/A
app pub date -
Jan 21, 1998
filing date -
Jan 21, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to controlled/extended release oral dosage forms of chromium picolinate. Chromium picolinate is a common and effective biologically active form of chromium. As such, it has beneficial nutritional and therapeutic effects including improved insulin metabolism and lipid lowering activity. The controlled dosage form of the present invention can be provided in various ways, including matrix formulations such as matrix tablets or multiparticulate formulations like micro capsules or coated pellets put into hard gelatin capsules. This provides effective drug delivery for extended periods of time, at relatively stable, optimal plasma peak values, with minimal undesirable side effects. The invention provides effective controlled/extended release oral dosage formulations of chromium picolinate and processes for their preparation.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully